Cited by 330Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisDiagnosis and treatment of tuberculosis

Tuberculosis in HIV-infected patients: a comprehensive review

Open access
Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B. +3 more·2004·Clinical Microbiology and Infection

Abstract

The incidence of tuberculosis (TB) is currently increasing in HIV-infected patients living in Africa and Asia, where TB endemicity is high, reflecting the susceptibility of this group of patients to mycobacteria belonging to the TB group. In this population, extension of multiple resistance to anti-tuberculous drugs is also a matter of anxiety. HIV-induced immunosuppression modifies the clinical presentation of TB, resulting in atypical signs and symptoms, and more frequent extrapulmonary dissemination. The treatment of TB is also more difficult to manage in HIV-infected patients, particularly with regard to pharmacological interactions secondary to inhibition or induction of cytochrome P450 enzymes by protease inhibitors with rifampicin or rifabutin, respectively. Finally, immune restoration induced by highly active anti-retroviral therapy (HAART) in developed countries may be responsible for a paradoxical worsening of TB manifestations.

Integrity signals

Registry

Crossref · 10.1111/j.1469-0691.2004.00758.x

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Extrapulmonary tuberculosis, including lymphatic tuberculosis, is more common among immunocompromised patients, including those with HIV infection.

    “Extrapulmonary tuberculosis, including lymphatic tuberculosis, is more common among immunocompromised patients, including those with HIV infection [20, 21].”
  • M tuberculosis lineage strains are associated with the site of tuberculosis disease; strains mostly distributed through Southeast Asia and the Indian Subcontinent (such as M tuberculosis Beijing/W strain) are more likely to cause extrapulmonary disease.

    “A few studies have shown that M tuberculosis lineage strains are associated with the site of tuberculosis disease. The strains mostly distributed through Southeast Asia and the Indian Subcontinent (such as M tuberculosis Beijing/W strain) are more likely to cause extrapulmonary disease.9–11”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O., Valeyre, D., & Lortholary, O.
Affiliations
  • Hôpital Necker-Enfants Malades (FR)
  • Hôpital Avicenne (FR)
  • Institut Pasteur (FR)
Corresponding author
Lortholary, O.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2004-05
Volume
10
Issue
5
Pages
388-398
ISSN
1198-743X (ISSN-L)
OpenAlex
W2095960037
Cited by
330
References
85
Citations by year
2026: 3 · 2025: 13 · 2024: 14 · 2023: 9 · 2022: 16 · 2021: 12 · 2020: 15 · 2019: 11 · 2018: 15 · 2017: 22 · 2016: 15 · 2015: 16 · 2014: 14 · 2013: 14 · 2012: 19
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Clinical Microbiology and Infection (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
  • Health Sciences › Medicine › Surgery › Diagnosis and treatment of tuberculosis
Keywords
tuberculosis, HIV infection, drug-resistant tuberculosis, extrapulmonary tuberculosis, atypical presentation, protease inhibitors, rifampicin, rifabutin, cytochrome P450 interactions, immune reconstitution, highly active antiretroviral therapy, Mycobacterium tuberculosis
MeSH terms
Antitubercular Agents, Drug Therapy, Combination, Humans, Tuberculosis, HIV Infections, AIDS-Related Opportunistic Infections, Tuberculosis, Multidrug-Resistant, Anti-HIV Agents, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review